30 July 2020 The City of Melbourne has helped hundreds of innovators and entrepreneurs start up or expand their businesses since 1996. They have also encouraged dozens of businesses to enter overseas markets and supported member-based organisations to…
29 July 2020 Melbourne-based, clinical-stage biopharmaceutical company Dimerix has reported excellent results from the clinical trial of its drug candidate DMX-200, which is aimed at a rare kidney disease called focal segmental glomerulosclerosis, or FSGS. FSGS is caused…
30 July 2020 A collaboration between Monash Health, the Australian Genomics Health Alliance (AGHA) and researchers at the Monash Biomedicine Discovery Institute has led to the discovery of a rare single gene mutation in a patient that eliminates…
30 July 2020 Hemideina, a hearing technology company enabling people with sensorineural hearing loss to enjoy a world of sound and to live life without limits, announced today that it was awarded a $660,000 BioMedTech Horizons (BMTH) Grant,…
28 July 2020 Nucleus Network is pleased to welcome Dr Robyn Langham to the team as Associate Medical Director and Principal Investigator. Robyn brings a wealth of knowledge with over 20 years of experience as a medical researcher…
29 July 2020 Highlights $5M raised in an oversubscribed placement at 4.5c per share – equivalent to 30 day VWAP, and a 33.9% premium to 60 day VWAP. Strongly supported by existing domestic institutional investors and sophisticated…
27 July 2020 La Trobe University is destined to achieve net zero carbon emissions by 2029 with the completion of an ambitious solar energy project at its Bundoora Campus. The University has today energised 7500 solar panels on…
27 July 2020 Burnet Institute Director and CEO Professor Brendan Crabb AC believes the critical importance of the community and community-informed research have been undersold in Australia’s response to the COVID-19 pandemic and need to be urgently prioritised.…
27 July 2020 Monash researchers have found a potential drug that can be given as a preventive against heart attack and stroke. The drug – which has been studied in human cells and animal models – literally blocks…
27 July 2020 A suite of new courses is set to equip health professionals with skills needed to keep pace with rapid technological advances in healthcare. RMIT Online and the Digital Health Cooperative Research Centre (CRC) have joined…
23 July 2020 Gilead Sciences today announced the appointment of Ric Morgan as the new Head of Legal and Compliance ANZ for Gilead Sciences in Australia and New Zealand (ANZ). Mr Morgan joins Gilead Sciences ANZ with more…
23 July 2020 AdAlta Limited (ASX:1AD), the clinical stage biotechnology company developing novel therapeutic products from its i-body platform is pleased to announce that the first healthy participants in the blinded Phase I clinical trial of AD-214 have…